Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

trastuzumab and hyaluronidase-oysk

trastuzumab and hyaluronidase-oysk
  • Non-formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Herceptin Hylecta POWDER FOR INJECTION, SUBCUTANEOUS 600 mg-10,000 units      
Comments:

Herceptin-Hylecta is non-formulary. May be used as patient own medication through the Prescription Assistance Program (PAP). Intravenous trastuzumab (Herceptin or biosimilar) are options for non PAP patients.

Reviewed October 22, 2019

Last updated: Oct. 24, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved